A detailed history of Paradigm Capital Management Inc transactions in Codexis, Inc. stock. As of the latest transaction made, Paradigm Capital Management Inc holds 100,000 shares of CDXS stock, worth $519,000. This represents 0.01% of its overall portfolio holdings.

Number of Shares
100,000
Previous 900,000 88.89%
Holding current value
$519,000
Previous $2.79 Million 88.96%
% of portfolio
0.01%
Previous 0.13%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$2.62 - $3.71 $2.1 Million - $2.97 Million
-800,000 Reduced 88.89%
100,000 $308,000
Q4 2023

Feb 13, 2024

BUY
$1.54 - $3.37 $616,000 - $1.35 Million
400,000 Added 80.0%
900,000 $2.75 Million
Q3 2023

Nov 13, 2023

BUY
$1.5 - $3.75 $300,000 - $750,000
200,000 Added 66.67%
500,000 $945,000
Q2 2023

Aug 14, 2023

BUY
$2.21 - $4.43 $221,000 - $443,000
100,000 Added 50.0%
300,000 $840,000
Q1 2023

May 12, 2023

BUY
$3.81 - $6.76 $762,000 - $1.35 Million
200,000 New
200,000 $827,000

Others Institutions Holding CDXS

About CODEXIS, INC.


  • Ticker CDXS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 65,494,100
  • Market Cap $340M
  • Description
  • Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...
More about CDXS
Track This Portfolio

Track Paradigm Capital Management Inc Portfolio

Follow Paradigm Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paradigm Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Paradigm Capital Management Inc with notifications on news.